{
    "title": "Rising Swiss rivalry as Roche and Novartis target same diseases",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8360537/Roche-Novartis-highlight-intensifying-rivalry-eye-disease-MS.html",
    "date": "2020-05-27",
    "keywords": [
        "roche",
        "novartis",
        "head",
        "miller",
        "eye",
        "sclerosis",
        "point",
        "port",
        "pds",
        "drug",
        "beovu",
        "michael",
        "approval",
        "zurich",
        "wednesday",
        "disease",
        "sign",
        "rivalry",
        "rhine",
        "basel",
        "competition",
        "chief",
        "executive",
        "severin",
        "schwan",
        "cancer",
        "treatment",
        "ceo",
        "vas",
        "narashiman",
        "territory",
        "delivery",
        "system",
        "version",
        "lucentis",
        "degeneration",
        "market",
        "medicine",
        "meanwhile",
        "arzerra",
        "shot",
        "blockbuster",
        "stake",
        "remnant",
        "twodecadeold",
        "merger",
        "bid",
        "dividend",
        "option",
        "directintheeye",
        "reservoir",
        "selling",
        "year",
        "zuercher",
        "analyst",
        "nawrath",
        "immune",
        "division",
        "mariefrance",
        "tschudin",
        "exposure",
        "coronavirus",
        "june",
        "reporting",
        "john",
        "alexander",
        "smith"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}